Jeff Lerch of CB Richard Ellis, who represented HemoCue in theplanning, selection, and negotiations for the site, says thecompany is expected to move into its new facility in December fromits current U.S. headquarters in nearby Mission Viejo. The companyhas leased the freestanding, single-story building for five yearsat a total consideration of $1.3 million. The concrete tilt-upR&D building, which includes office space as well as labs, wascompleted in 1999.

HemoCue develops, produces and markets medical diagnosticproducts for point-of-care testing. The fundamental concept behindthe HemoCue products is to perform common blood tests at thepoint-of-care without sacrificing the accuracy and precisionoffered by a central clinical lab. The company's customers includeblood banks, medical offices, public health care screeningprograms, hospital emergency rooms, operating rooms, dialysisclinics and outpatient surgery centers.

HemoCue, Inc. is wholly owned by its Swedish parent, HemoCueHolding AB, based in Angelholm, Sweden. The company sells itsproducts in more than 75 countries and is considered a leader inpoint-of-care blood testing.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.